UK markets closed

NIKKEI 225
38,923.03
+435.13(+1.13%)
HANG SENG
18,403.04
+323.43(+1.79%)
CRUDE OIL
74.28
-2.71(-3.52%)
GOLD FUTURES
2,367.50
+21.70(+0.93%)
DOW
38,302.07
-384.25(-0.99%)
Bitcoin GBP
54,133.16
+913.23(+1.72%)

Trending tickers: GameStop, Bitcoin, Saudi Aramco and Hipgnosis

The latest investor updates on stocks that are trending on Monday

BMY May 2025 33.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.4200

0.0000

(0.00%)

As of 11:18AM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....